---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-014652"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:14:25.710948+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma issues 10M shares to CEO in settlement of $50K accrued salary

## Summary
- Issued 10,000,000 common shares to CEO David R. Koos as settlement for $50,000 of accrued unpaid salary.
- Shares issued under Section 4(a)(2) exempt offering; no underwriters or commissions paid.
- Settlement agreement (Ex-10.1) reveals total unpaid salary of $457,113.19; only $50K settled with shares.
- Post-issuance, shares outstanding increased to 31,554,704 from ~21.6M, a ~46% dilution.

## SEC filing metadata
- accession: 0001641172-25-014652
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000164117225014652/0001641172-25-014652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000164117225014652/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-014652
- JSON: https://secwatch.observer/filing/0001641172-25-014652.json
- Plain text: https://secwatch.observer/filing/0001641172-25-014652.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.